Millennium Pharmaceuticals is a biotechnology company that is dedicated to the discovery and development of new drugs via the application of genomics. Since the company's inception in 1993, Millennium has been successful in getting lucrative research and development contracts with pharmaceutical companies.
Millennium leverages its advanced drug discovery technology platform to allow researchers quickly identify genes that may be associated with a particular disease. Millennium has built an organization with the capability of discovering new drug, taking it through clinical trials, and marketing it.
The company focuses on three fields: oncology, inflammation, and metabolic disease. Millennium has a strong oncology commercial presence and is responsible for the promotion of VELCADE within the United States. The commercial team at Millennium provides services that include full scale reimbursement assistance, patient advocacy, liaisons with global medical affairs as well as health system and oncology based specialists.